pharmaceuticals

Is Spectrum Pharma Getting Enough for Its Hematology/Oncology Portfolio?

Posted: January 17, 2019 at 12:00 pm

Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI) shares made a handy gain early Thursday after the firm announced that it would be selling its portfolio of seven FDA-approved hematology/oncology products to Acrotech ...
Read Full Story »

Major Pharma Sees Fading Short Interest

Posted: January 11, 2019 at 9:50 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Are Loxo Shareholders Getting Enough in the Buyout?

Posted: January 7, 2019 at 11:05 am

Loxo Oncology Inc. (NASDAQ: LOXO) shares made a massive gain on Monday after it was announced that the firm would be acquired by Eli Lilly and Co. (NYSE: LLY). The ...
Read Full Story »

Major Biopharma Catalysts Coming in the First Quarter of 2019

Posted: January 7, 2019 at 8:35 am

Biotech and pharmaceutical companies generally are involved in the lengthy process of getting their drug candidates to market through clinical trials. The amount of risk involved ranges from fair to ...
Read Full Story »

Teva and Amgen Settle Over Kidney Disease Patent Infringement

Posted: January 3, 2019 at 1:25 pm

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced on Thursday that it has settled with Amgen Inc. (NASDAQ: AMGN) for its treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney ...
Read Full Story »

Bristol-Myers, Celgene to Tie a $74 Billion Knot

Posted: January 3, 2019 at 8:50 am

There's nothing like spending $74 billion on an acquisition to get shareholders' attention. That's what Bristol-Myers Squibb Co. (NYSE: BMY) found out Thursday morning following the announcement of a definitive ...
Read Full Story »

Merck’s Blockbuster Cancer Drug Keytruda Wins Multiple Approvals in Japan

Posted: January 3, 2019 at 8:45 am

Merck & Co. Inc. (NYSE: MRK) has announced that its blockbuster drug Keytruda received a series of approvals in Japan. The firm said that its anti-PD-1 therapy has simultaneously received ...
Read Full Story »

Is Spectrum Pharma’s FDA Update Good News for Breast Cancer Patients?

Posted: December 27, 2018 at 11:40 am

Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI) shares dipped on Thursday after the firm announced a key update from the U.S. Food and Drug Administration (FDA). Specifically, the firm announced that it ...
Read Full Story »

Short Sellers Hike Bets in Major Pharma Stocks

Posted: December 27, 2018 at 10:00 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Meet Thursday’s Biggest Biotech Movers

Posted: December 20, 2018 at 11:40 am

Thursday was a breakout day for a few biotech companies. Some made absolutely massive runs, while others fell off a cliff. Although the sector is feeling the pinch from the ...
Read Full Story »

Meet Pfizer and GlaxoSmithKline’s New Joint Venture

Posted: December 19, 2018 at 11:40 am

GlaxoSmithKline PLC (NYSE: GSK) shares bounced higher on Wednesday after the company announced a new joint venture with Pfizer Inc. (NYSE: PFE). These two firms will create a premier global ...
Read Full Story »

Eli Lilly Scores Solid Results in Psoriatic Arthritis Study

Posted: December 17, 2018 at 10:10 am

Eli Lilly and Co. (NYSE: LLY) has announced positive results from its late-stage active psoriatic arthritis (PsA) study. This trial is the first completed large head-to-head superiority study in active ...
Read Full Story »

Johnson & Johnson Under Fire After Claims of Asbestos in Baby Powder

Posted: December 14, 2018 at 11:35 am

Reuters reported on Friday that Johnson & Johnson (NYSE: JNJ) knew for decades that its baby powder sometimes contained the known carcinogen asbestos. According to the report, the pharmaceutical and health ...
Read Full Story »

Eli Lilly Receives Crucial FDA Update on Lupus Study

Posted: December 13, 2018 at 10:15 am

The U.S. Food and Drug Administration (FDA) has granted a Fast Track designation to Eli Lilly and Co.'s (NYSE: LLY) baricitinib, which is being studied for the treatment of systemic lupus ...
Read Full Story »

Major Pharma Stocks See a Surge in Short Interest

Posted: December 12, 2018 at 9:50 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »